Getein Biotech, Inc (603387.SS) SHH

8.30

+0.05(+0.61%)

Updated at December 25 02:56PM

Currency In CNY

Valuation

Market Cap4.19B
Enterprise Value4.42B
P/E Ratio20.14
PEG Ratio-8.66
Price/Sales Ratio4.03
Price/Book Ratio1.56
Enterprise/Revenue4.31
Enterprise/EBITDA19.84

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.2
Operating Margin0.19

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue1.16B
Revenue/Share2.06
Gross Profit806.37M
EBITDA362.01M
Net Income223.64M
Diluted EPS0.44

Balance Sheet

Total Cash1.14B
Total Cash/Share2.25
Total Debt631.03M
Total Debt/Equity0.23
Current Ratio2.32
Book Value Per Share5.52

Price History

52-Week Change0.24
52-Week High9.08
52-Week Low7.31
Moving Average 50 Days8.32
Moving Average 200 Days8.29

Statistics

Average Volume5.26M
Shares Outstanding507.15M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.18
Trailing Annual Dividend Yield2.17
Payout Ratio0.26
Last Split Factor7:5
Last Split DateJune 08, 2022